Medical Update on Acute Myelogenous Leukemia (AML)
This podcast was originally published on cancercare.org by Mary-Elizabeth Percival, Eytan M. Stein, Carolyn Messner on June 14, 2019, you can find it here.
Topics Covered
- Overview of Acute Myelogenous Leukemia (AML)
- Current Treatment Approaches
- Transplantation as a Treatment Option for AML
- New Therapies
- The Role of Clinical Trials: How They Increase Your Treatment Options
- Clinical Trial Updates
- Symptom, Side Effect & Pain Management Tips
- Key Questions to Ask Your Health Care Team
- Quality-of-Life Concerns
- Questions for Our Panel of Experts
Panel of Experts
Mary-Elizabeth Percival, MD, MS
Assistant Professor of Medicine (Hematology), University of Washington, Assistant Member (Clinical Research Division), Fred Hutchinson Cancer Research Center, Attending Physician, Seattle Cancer Care Alliance
Eytan M. Stein, MD
Hematologic Oncologist, Clinical Trialist, Acute Myeloid Leukemia, Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center
Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW
Director of Education and Training, CancerCare